Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 30;2013(4):CD009920.
doi: 10.1002/14651858.CD009920.pub2.

Intra-articular glucocorticoids for acute gout

Mihir D Wechalekar  1 , Ophir Vinik, Naomi Schlesinger, Rachelle Buchbinder
Affiliations

Intra-articular glucocorticoids for acute gout

Mihir D Wechalekar et al. Cochrane Database Syst Rev. .

Abstract

Background: Although intra-articular glucocorticoids are a commonly used intervention in the treatment of acute gout, there is little evidence to support their safety and efficacy in this setting.

Objectives: To evaluate the safety and efficacy of intra-articular glucocorticoids in the treatment of acute gout.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library), Ovid MEDLINE and Ovid EMBASE for studies to 16th October 2012. We also searched the 2010 to 2011 American College of Rheumatology (ACR) and European League against Rheumatism (EULAR) abstracts and performed a handsearch of the reference lists of articles considered for inclusion.

Selection criteria: Studies were eligible for inclusion if they were randomised controlled trials (RCTs) or controlled clinical trials (CCTs) that used quasi-randomisation methods to allocate participants to treatment and compared intra-articular glucocorticoids to another therapy (active or placebo) in adults with acute gout. Outcomes selected for inclusion were pain, the proportion of participant withdrawals due to adverse events, inflammation, function, patient global assessment of treatment success, quality of life and proportion of particpants with serious adverse events.

Data collection and analysis: Two review authors independently selected the studies for inclusion and planned to extract the data and perform a risk of bias assessment.

Main results: No trials were identified that evaluated the efficacy and safety of intra-articular glucocorticoids for acute gout.

Authors' conclusions: There is presently no evidence from randomised trials to support the use of intra-articular glucocorticoid treatment in acute gout. Evidence suggests intra-articular glucocorticoids may be a safe and effective treatment in osteoarthritis and rheumatoid arthritis. These results may be generalisable to people with acute gout, and the treatment may be especially useful in people when non-steroidal anti-inflammatory drugs or colchicine are contraindicated.

PubMed Disclaimer

Conflict of interest statement

None

Figures

1
1
Study flow diagram.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD009920

References

References to studies excluded from this review

Fernandez 1999 {published data only}
    1. Fernandez C, Noguera R, Gonzalez JA, Pascual E. Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide. Journal of Rheumatology 1999;26:2285‐6. - PubMed
Komatsu 1969 {published data only}
    1. Komatsu T. [Treatment of acute gouty attack with local infiltration of Kenacort‐A and the study of gout and hyperuricemia at the Tanabe National Hospital during 1967]. Iryo 1969;23:54‐61. - PubMed

Additional references

Bellamy 2006
    1. Bellamy N, Campbell J, Welch V, Gee Travis L, Bourne R, Wells George A. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD005328.pub2] - DOI - PubMed
Cates 2008
    1. Cates CD. Visual Rx Version 3 NNT Calculator [Computer program]. Dr Chris Cates EBM website. Available from http://www.nntonline.net/ 2008.
Courtney 2005
    1. Courtney P, Doherty M. Joint aspiration and injection. Best Practice & Research: Clinical Rheumatology 2005;19(3):345‐69. - PubMed
Courtney 2009
    1. Courtney P, Doherty M. Joint aspiration and injection and synovial fluid analysis. Best Practice & Research: Clinical Rheumatology 2009;23(2):161‐92. - PubMed
Creamer 1997
    1. Creamer P. Intra‐articular corticosteroid injections in osteoarthritis: do they work and if so, how?. Annals of the Rheumatic Diseases 1997;56:634‐5. - PMC - PubMed
DeAngelis 2004
    1. DeAngelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 2004;292(11):1363‐4. - PubMed
Deeks 2011
    1. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Dieppe 1980
    1. Dieppe PA, Sathapatayavongs B, Jones HE, Bacon PA, Ring EF. Intra‐articular steroids in osteoarthritis. Rheumatology and Rehabilitation 1980;19(4):212‐7. [PUBMED: 7010511] - PubMed
Friedman 1980
    1. Friedman DM, Moore ME. The efficacy of intraarticular steroids in osteoarthritis: a double‐blind study. Journal of Rheumatology 1980;7(6):850‐6. [PUBMED: 7009857] - PubMed
Godwin 2004
    1. Godwin M, Dawes M. Intra‐articular steroid injections for painful knees. Systematic review with meta‐analysis. Canadian Family Physician 2004;50:241‐8. [PUBMED: 15000335] - PMC - PubMed
Grainger 2009
    1. Grainger R, Taylor WJ, Dalbeth N, Perez‐Ruiz F, Singh JA, Waltrip RW, et al. Progress in measurement instruments for acute and chronic gout studies. Journal of Rheumatology 2009;36(10):2346‐55. - PubMed
Hamburger 2011
    1. Hamburger M, Baraf HS, Adamson TC 3rd, Basile J, Bass L, Cole B, et al. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia. Postgraduate Medicine 2011;123(6 Suppl 1):3‐36. [PUBMED: 22156509] - PubMed
Higgins 2011a
    1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Higgins 2011b
    1. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Higgins 2011c
    1. Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Jacobs 2008
    1. Jacobs JWG, Bijlsma JWJ. Glucocorticoid therapy. In: Firestein GS, Budd RC, Harris Jr ED, McInnes IB, Ruddy S, Sergent JS editor(s). Firestein: Kelly's Textbook of Rheumatology. 8th Edition. Philadelphia, PA: Saunders Elsevier, 2008:863‐81.
Janssens 2008a
    1. Janssens HJ, Lucassen PLBJ, Laar FA, Janssen M, Lisdonk EH. Systemic corticosteroids for acute gout. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD005521.pub2] - DOI - PMC - PubMed
Janssens 2008b
    1. Janssens HJ, Janssen M, Lisdonk EH, Riel PL, Weel C. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double‐blind, randomised equivalence trial. Lancet 2008;371(9627):1854‐60. [PUBMED: 18514729] - PubMed
Jordan 2007
    1. Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology 2007;46:1372‐4. - PubMed
Khanna 2012
    1. Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Snagmee BAE, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care and Research 2012;64(10):1447–61. - PMC - PubMed
Kim 2002
    1. Kim PS. Role of injection therapy: review of indications for trigger point injections, regional blocks, facet joint injections, and intra‐articular injections. Current Opinion in Rheumatology 2002;14(1):52‐7. - PubMed
Moher 2012
    1. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. International Journal of Surgery 2012;10(1):28‐55. [PUBMED: 22036893] - PubMed
Neogi 2011
    1. Neogi T. Gout. New England Journal of Medicine 2011;364:443‐52. - PubMed
O'Sullivan 1972
    1. O'Sullivan JB. Gout in a New England town. A prevalence study in Sudbury, Massachusetts. Annals of the Rheumatic Diseases 1972;31(3):166‐9. [PUBMED: 5032448] - PMC - PubMed
RevMan 2011 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Richette 2010
    1. Richette P, Bardin T. Gout. Lancet 2010;375:318‐28. - PubMed
Schumacher 2005
    1. Schumacher HR Jr, Edwards LN, Perez‐Ruiz F, Becker M, Chen LX, Furst DE, et al. Outcome measures for acute and chronic gout. Journal of Rheumatology 2005;32:2452‐5. - PubMed
Schünemann 2011a
    1. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Schünemann 2011b
    1. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Stahn 2008
    1. Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nature Clinical Practice Rheumatology 2008;4:525‐33. - PubMed
Sterne 2011
    1. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Wallace 1977
    1. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü T‐F. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis and Rheumatism 1977;20:895‐900. - PubMed
Wallen 2006
    1. Wallen MM, Gillies D. Intra‐articular steroids and splints/rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD002824.pub2] - DOI - PMC - PubMed
Zhang 2006
    1. Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases 2006;65:1312‐24. - PMC - PubMed

Publication types

Substances

LinkOut - more resources